These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9178651)

  • 1. The role of 5-HT(1B/1D) receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig.
    Roberts C; Price GW; Jones BJ
    Eur J Pharmacol; 1997 May; 326(1):23-30. PubMed ID: 9178651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regions.
    Roberts C; Belenguer A; Middlemiss DN; Routledge C
    Eur J Pharmacol; 1998 Apr; 346(2-3):175-80. PubMed ID: 9652357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade.
    Roberts C; Boyd DF; Middlemiss DN; Routledge C
    Neuropharmacology; 1999 Sep; 38(9):1409-19. PubMed ID: 10471095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo.
    Stenfors C; Magnusson T; Larsson LG; Yu H; Hållbus M; Magnusson O; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Feb; 359(2):110-6. PubMed ID: 10048595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.
    McCreary AC; Bankson MG; Cunningham KA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):965-73. PubMed ID: 10454466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
    Hervás I; Artigas F
    Eur J Pharmacol; 1998 Sep; 358(1):9-18. PubMed ID: 9809863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus.
    Starkey SJ; Skingle M
    Neuropharmacology; 1994; 33(3-4):393-402. PubMed ID: 7984277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of 5-HT1D autoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe, hippocampus and frontal cortex.
    el Mansari M; Blier P
    Br J Pharmacol; 1996 Jun; 118(3):681-9. PubMed ID: 8762094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
    Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release.
    Gobert A; Rivet JM; Audinot V; Newman-Tancredi A; Cistarelli L; Millan MJ
    Neuroscience; 1998 May; 84(2):413-29. PubMed ID: 9539213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R; Bramante M; Samanin R
    Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo.
    Rollema H; Clarke T; Sprouse JS; Schulz DW
    J Neurochem; 1996 Nov; 67(5):2204-7. PubMed ID: 8863532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT 1B/D receptor antagonists.
    Pauwels PJ
    Gen Pharmacol; 1997 Sep; 29(3):293-303. PubMed ID: 9378233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
    Knobelman DA; Hen R; Blendy JA; Lucki I
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.
    de Groote L; Olivier B; Westenberg HG
    Psychopharmacology (Berl); 2002 Aug; 162(4):419-24. PubMed ID: 12172696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
    Bühlen M; Fink K; Böing C; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.